Matinas biopharma initiates dosing in phase 1 study of potential first oral aminoglycoside antibiotic drug mat2501

– phase 1 study of oral amikacin in healthy volunteers expected to complete in q1 2022 – – phase 1 study of oral amikacin in healthy volunteers expected to complete in q1 2022 –

MTNB Ratings Summary

MTNB Quant Ranking